| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13f23c0ba8ee6f80e89543d0edf02b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05f06e9ea66e72ffa8c5fda8fc05c3ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c54f79044c97d3452aad396c92030a5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48d4ac5e6190a0bdcebe32e78e3d11df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c60e10a2ad42a748a43c2aa0ee556bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ea2023218fe9e1ad9396ff543300796 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-00 |
| filingDate |
2010-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3265d0c144e8de7b8a3fde8ec2d99c59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27f2f11e63d12fc8c3955f852cd6957
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ad924593a399f97377dec4b7f7da1fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74947d9de450020215fca099a914f72f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b343de2615fd0abcd885c6dd23ae789 |
| publicationDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8580793-B2 |
| titleOfInvention |
Use of kinase inhibitor for the treatment of thymoma |
| abstract |
The invention provides a low molecular weight ATP-competitive CDK inhibitor and TRKA inhibitor of formula (I) for use in the treatment of thymoma and thymic carcinoma. The compound can be administered together with one or more cytotoxic or cytostatic agents. |
| priorityDate |
2009-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |